...In addition, pursuant to the Waiver and Consent, Idenix granted Novartis Pharma the right to designate an additional director to serve on its Board of Directors (the “Board”)
as per this recent event... do you expect it was NVS that requested the additional board member? is this the norm?
The creation of a thousand forests is in one acorn.